Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT03117946
NA
Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy
Sponsor: Centre Hospitalier Universitaire de Besancon
View on ClinicalTrials.gov
Summary
The aim of this study is to evaluate modulation of anti-tumor T cell responses in cancer patients treated by concomitant radiochemotherapy (i-RTCT)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
136
Start Date
2017-05-29
Completion Date
2025-01-09
Last Updated
2026-07-23
Healthy Volunteers
No
Conditions
Interventions
OTHER
Biological samples
blood and tumor tissue sample
Locations (4)
CHU de Besançon
Besançon, France, France
Centre Georges François LECLERC
Dijon, France
Hôpital Nord Franche-Comté
Montbéliard, France
Institut Jean Godinot
Reims, France